Bay­er breaks off Covid-19 vac­cine man­u­fac­tur­ing pact as Cure­Vac piv­ots to sec­ond-gen work — re­port

As Cure­Vac strives to con­vince the world that it won’t let its dis­ap­point­ing first-gen­er­a­tion mR­NA Covid-19 vac­cine hold it down, Bay­er re­port­ed­ly won’t be stick­ing around to help man­u­fac­ture the new can­di­dates.

“Joint­ly with Cure­Vac we have de­cid­ed by mu­tu­al agree­ment to not con­tin­ue the co­op­er­a­tion,” a Bay­er spokesper­son told Ger­man news­pa­per Rheinis­che Post, per Reuters.

When reached by End­points News, Cure­Vac de­clined to con­firm the ter­mi­na­tion but did not of­fer any fur­ther ex­pla­na­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER